Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Enterprise Value (2015 - 2026)

Kamada's (KMDA) quarterly Enterprise Value came in at $353.3 million in Q2 2026, down 6.95% on a YoY basis from $379.7 million in Q2 2025, and down 13.4% quarter-over-quarter from $408.0 million in Q1 2026.

Analysis

Kamada (KMDA) Enterprise Value (2015 - 2026) Analysis & Trends

Kamada (KMDA) has reported Enterprise Value for 12 consecutive years, with $353.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Enterprise Value fell 6.95% year-over-year to $353.3 million; the trailing twelve-month figure through Jun 2026 stood at $353.3 million (down 6.95% YoY), and the FY2025 full-year result was $256.3 million, up 32.58% from the prior year.
  • Enterprise Value eased to $353.3 million in Q2 2026 per KMDA's latest filing, from $408.0 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $408.0 million in Q1 2026 and bottomed at $142.7 million in Q4 2022.
  • Historically, Enterprise Value has averaged $251.4 million across 5 years, with a median of $232.6 million in 2024.
  • The widest YoY moves for Enterprise Value: up 68.56% in 2023, down 19.62% in 2023.
  • Over 5 years, Enterprise Value stood at $142.7 million in 2022, then jumped by 68.56% to $240.5 million in 2023, then decreased by 19.61% to $193.3 million in 2024, then surged by 32.58% to $256.3 million in 2025, then soared by 37.83% to $353.3 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered $353.3 million, $408.0 million, and $256.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 353.28 Mn
Mar 31, 2026 407.95 Mn
Dec 31, 2025 256.33 Mn
Sep 30, 2025 327.09 Mn
Jun 30, 2025 379.68 Mn
Mar 31, 2025 303.86 Mn
Dec 31, 2024 193.34 Mn
Sep 30, 2024 236.66 Mn
Jun 30, 2024 228.55 Mn
Mar 31, 2024 274.27 Mn
Dec 31, 2023 240.49 Mn
Sep 30, 2023 186.80 Mn
Jun 30, 2023 214.71 Mn
Mar 31, 2023 181.13 Mn
Dec 31, 2022 142.67 Mn
Sep 30, 2022 170.80 Mn
Jun 30, 2022 202.02 Mn
Mar 31, 2022 225.33 Mn
Dec 31, 2021 149.49 Mn
Sep 30, 2021 137.30 Mn